Learn more about the genetic tests and reports that are coming soon or are in development for the MyOme Personal Genome platform. MyOme Personal Genome unlocks a lifetime of health information from only one sample submission, and our MyOme Genetic Tests cover a range of clinical conditions*.
The report provides a single risk score that integrates genetics with clinical factors to assess risk for coronary artery disease (CAD) for those who may be missed by clinical evaluation (whereas traditional genetic panels evaluate rare genes impacting a small percent and do not assess CAD risk).
Nearly 1 in 8 women in the U.S. will develop invasive breast cancer throughout their lives.2 We’re developing this report to offer women on-demand access to their breast cancer risk at any age. See our publication on breast cancer risk stratification.
1. National Center for Health Statistics. Multiple Cause of Death 2018–2021 on CDC WONDER Database. Accessed September 13, 2023.2. Breast Cancer Facts and Statistics 2023, www.breastcancer.org/facts-statistics. Accessed 13 Sept. 2023.3. Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Ann Oncol. 2015 Jul;26(7):1291-9. doi: 10.1093/annonc/mdv022. Epub 2015 Jan 20. PMID: 25605744; PMCID: PMC4478970.4. Tshiaba, P., et al. Improved Breast Cancer Risk Stratification by Integration of a Cross-ancestry Polygenic Model with Clinical Risk Factors # PB3447 Presented at the Annual Meeting of The American Society of Human Genetics, October 27, 2022, Los Angeles5. Savatt Juliann M. et al, Frontiers in Pediatrics V92021* In some cases an additional sample might be required.
We are happy to answer any questions. Contact us at *protected email* with any questions or to keep apprised of any development, provide your name and email information.
OFFICE and LAB: Menlo Park, California